Cognigenics develops innovative RNA-based gene therapies targeting memory loss, cognitive decline, anxiety associated with mild cognitive impairment and other neurocognitive and neuropsychiatric disorders. Our intranasal delivery platform targets neuronal receptors in the brain involved in CNS disorders including anxiety, and Mild Cognitive Impairment.
| Website | http://cognigenics.io |
| Employees | 19 (9 on RocketReach) |
| Founded | 2019 |
| Address | 770 South Indian Street Suite 105, Stuart, Florida 34997, US |
| Technologies |
JavaScript
,
HTML
,
Twitter
+5 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Rna Therapy, Gene Therapy, Memory Loss Treatment, Anxiety Treatment, Mild Cognitive Impairment, Neurocognitive Disorders, Neuropsychiatric Disorders, Innovative Therapies, Rna Therapeutics, Drug Delivery Platform, Neurological Disorders, Brain Health, Cognitive Enhancement, Neurological Treatment, Biotechnology, Pharmaceutical, Clinical Trials, New Treatments |
| Competitors | Siemens, Roche, Thermo Fisher Scientific, Agilent Technologies, Illumina, GeneDx, Bionano Genomics, Inc., QIAGEN, Asuragen, GENOOX +42 more (view full list) |
Looking for a particular Cognigenics employee's phone or email?
Tracy Brandmeyer is the Co-Founder and CEO of Cognigenics.
9 people are employed at Cognigenics.
Cognigenics is based in Stuart, Florida.